 | • レポートコード：20QY06-02210 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ゾニサミドのグローバル市場について種類別（25mg、50mg、100mg）、用途別（成人、小児、老人病）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ゾニサミド市場の概要 ・世界の主要地域別ゾニサミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のゾニサミド市場規模2015-2026：種類別（25mg、50mg、100mg） ・世界のゾニサミド市場規模2015-2026：用途別（成人、小児、老人病） ・ゾニサミドの北米市場規模2015-2020 ・ゾニサミドのヨーロッパ市場規模2015-2020 ・ゾニサミドの中国市場規模2015-2020 ・ゾニサミドの日本市場規模2015-2020 ・ゾニサミドの東南アジア市場規模2015-2020 ・ゾニサミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Concordia、Eisai、Zydus Pharmaceuticals、Sun Pharma、Wockhardt、Mylan、APOTEX、Teva、Glenmark、Bluepharma、Invagen Pharmaceuticals、Intas Pharmaceuticals） ・ゾニサミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ゾニサミドの市場動向・機会・課題 ・調査の結論 |
Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson’s disease.
Market Analysis and Insights: Global Zonisamide Market
The global Zonisamide market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Zonisamide Scope and Market Size
The global Zonisamide market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Zonisamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Zonisamide market is segmented into
25mg
50mg
100mg
Segment by Application, the Zonisamide market is segmented into
Adult
Pediatric
Geriatric
The Zonisamide market is analysed and market size information is provided by regions (countries). Segment by Application, the Zonisamide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Zonisamide Market Share Analysis
Zonisamide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Zonisamide business, the date to enter into the Zonisamide market, Zonisamide product introduction, recent developments, etc.
The major vendors covered:
Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Table of Contents
1 Zonisamide Market Overview
1.1 Zonisamide Product Scope
1.2 Zonisamide Segment by Type
1.2.1 Global Zonisamide Sales by Type (2020-2026)
1.2.2 25mg
1.2.3 50mg
1.2.4 100mg
1.3 Zonisamide Segment by Application
1.3.1 Global Zonisamide Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Pediatric
1.3.4 Geriatric
1.4 Zonisamide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Zonisamide Sales Growth Rate (2015-2026)
1.4.2 Global Zonisamide Revenue and Growth Rate (2015-2026)
1.4.3 Global Zonisamide Price Trends (2015-2026)
2 Zonisamide Estimate and Forecast by Region
2.1 Global Zonisamide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Zonisamide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Zonisamide Sales Market Share by Region (2015-2020)
2.2.2 Global Zonisamide Revenue Market Share by Region (2015-2020)
2.3 Global Zonisamide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Zonisamide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Zonisamide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Zonisamide Estimates and Projections (2015-2026)
2.4.2 Europe Zonisamide Estimates and Projections (2015-2026)
2.4.3 China Zonisamide Estimates and Projections (2015-2026)
2.4.4 Japan Zonisamide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Zonisamide Estimates and Projections (2015-2026)
2.4.6 India Zonisamide Estimates and Projections (2015-2026)
3 Global Zonisamide Competition Landscape by Players
3.1 Global Top Zonisamide Players by Sales (2015-2020)
3.2 Global Top Zonisamide Players by Revenue (2015-2020)
3.3 Global Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zonisamide as of 2019)
3.4 Global Zonisamide Average Price by Company (2015-2020)
3.5 Manufacturers Zonisamide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Zonisamide Players (Opinion Leaders)
4 Global Zonisamide Market Size by Type
4.1 Global Zonisamide Historic Market Review by Type (2015-2020)
4.1.1 Global Zonisamide Sales Market Share by Type (2015-2020)
4.1.2 Global Zonisamide Revenue Market Share by Type (2015-2020)
4.1.3 Global Zonisamide Price by Type (2014-2020)
4.2 Global Zonisamide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Zonisamide Sales Forecast by Type (2021-2026)
4.2.2 Global Zonisamide Revenue Forecast by Type (2021-2026)
4.2.3 Global Zonisamide Price Forecast by Type (2021-2026)
5 Global Zonisamide Market Size by Application
5.1 Global Zonisamide Historic Market Review by Application (2015-2020)
5.1.1 Global Zonisamide Sales Market Share by Application (2015-2020)
5.1.2 Global Zonisamide Revenue Market Share by Application (2015-2020)
5.1.3 Global Zonisamide Price by Application (2015-2020)
5.2 Global Zonisamide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Zonisamide Sales Forecast by Application (2021-2026)
5.2.2 Global Zonisamide Revenue Forecast by Application (2021-2026)
5.2.3 Global Zonisamide Price Forecast by Application (2021-2026)
3 North America Zonisamide Market Facts & Figures
3.2 North America Zonisamide Sales Market Share by Company (2015-2020)
3.3 North America Zonisamide Sales Market Share by Type (2015-2020)
3.4 North America Zonisamide Sales Market Share by Application (2015-2020)
4 Europe Zonisamide Market Facts & Figures
4.2 Europe Zonisamide Sales Market Share by Company (2015-2020)
4.3 Europe Zonisamide Sales Market Share by Type (2015-2020)
4.4 Europe Zonisamide Sales Market Share by Application (2015-2020)
5 China Zonisamide Market Facts & Figures
5.2 China Zonisamide Sales Market Share by Company (2015-2020)
5.3 China Zonisamide Sales Market Share by Type (2015-2020)
5.4 China Zonisamide Sales Market Share by Application (2015-2020)
6 Japan Zonisamide Market Facts & Figures
6.2 Japan Zonisamide Sales Market Share by Company (2015-2020)
6.3 Japan Zonisamide Sales Market Share by Type (2015-2020)
6.4 Japan Zonisamide Sales Market Share by Application (2015-2020)
7 Southeast Asia Zonisamide Market Facts & Figures
7.2 Southeast Asia Zonisamide Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Zonisamide Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Zonisamide Sales Market Share by Application (2015-2020)
8 India Zonisamide Market Facts & Figures
8.2 India Zonisamide Sales Market Share by Company (2015-2020)
8.3 India Zonisamide Sales Market Share by Type (2015-2020)
8.4 India Zonisamide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Zonisamide Business
12.1 Concordia
12.1.1 Concordia Zonisamide Corporation Information
12.1.2 Concordia Zonisamide Business Overview and Total Revenue
12.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Concordia Zonisamide Products Offered
12.1.5 Concordia Recent Development
12.2 Eisai
12.2.1 Eisai Zonisamide Corporation Information
12.2.2 Eisai Zonisamide Business Overview and Total Revenue
12.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eisai Zonisamide Products Offered
12.2.5 Eisai Recent Development
12.3 Zydus Pharmaceuticals
12.3.1 Zydus Pharmaceuticals Zonisamide Corporation Information
12.3.2 Zydus Pharmaceuticals Zonisamide Business Overview and Total Revenue
12.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Zydus Pharmaceuticals Zonisamide Products Offered
12.3.5 Zydus Pharmaceuticals Recent Development
12.4 Sun Pharma
12.4.1 Sun Pharma Zonisamide Corporation Information
12.4.2 Sun Pharma Zonisamide Business Overview and Total Revenue
12.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharma Zonisamide Products Offered
12.4.5 Sun Pharma Recent Development
12.5 Wockhardt
12.5.1 Wockhardt Zonisamide Corporation Information
12.5.2 Wockhardt Zonisamide Business Overview and Total Revenue
12.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Wockhardt Zonisamide Products Offered
12.5.5 Wockhardt Recent Development
12.6 Mylan
12.6.1 Mylan Zonisamide Corporation Information
12.6.2 Mylan Zonisamide Business Overview and Total Revenue
12.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Zonisamide Products Offered
12.6.5 Mylan Recent Development
12.7 APOTEX
12.7.1 APOTEX Zonisamide Corporation Information
12.7.2 APOTEX Zonisamide Business Overview and Total Revenue
12.7.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.7.4 APOTEX Zonisamide Products Offered
12.7.5 APOTEX Recent Development
12.8 Teva
12.8.1 Teva Zonisamide Corporation Information
12.8.2 Teva Zonisamide Business Overview and Total Revenue
12.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Teva Zonisamide Products Offered
12.8.5 Teva Recent Development
12.9 Glenmark
12.9.1 Glenmark Zonisamide Corporation Information
12.9.2 Glenmark Zonisamide Business Overview and Total Revenue
12.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Glenmark Zonisamide Products Offered
12.9.5 Glenmark Recent Development
12.10 Bluepharma
12.10.1 Bluepharma Zonisamide Corporation Information
12.10.2 Bluepharma Zonisamide Business Overview and Total Revenue
12.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bluepharma Zonisamide Products Offered
12.10.5 Bluepharma Recent Development
12.11 Invagen Pharmaceuticals
12.11.1 Invagen Pharmaceuticals Zonisamide Corporation Information
12.11.2 Invagen Pharmaceuticals Zonisamide Business Overview and Total Revenue
12.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Invagen Pharmaceuticals Zonisamide Products Offered
12.11.5 Invagen Pharmaceuticals Recent Development
12.12 Intas Pharmaceuticals
12.12.1 Intas Pharmaceuticals Zonisamide Corporation Information
12.12.2 Intas Pharmaceuticals Zonisamide Business Overview and Total Revenue
12.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Intas Pharmaceuticals Zonisamide Products Offered
12.12.5 Intas Pharmaceuticals Recent Development
13 Zonisamide Manufacturing Cost Analysis
13.1 Zonisamide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Zonisamide
13.4 Zonisamide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Zonisamide Distributors List
14.3 Zonisamide Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Zonisamide Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Zonisamide Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Zonisamide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Zonisamide Sales (K MT) by Region (2015-2020)
Table 5. Global Zonisamide Sales Market Share by Region (2015-2020)
Table 6. Global Zonisamide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Zonisamide Revenue Share by Region (2015-2020)
Table 8. Global Zonisamide Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Zonisamide Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Zonisamide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Zonisamide Revenue Share Forecast by Region (2021-2026)
Table 12. Global Zonisamide (K MT) of Key Companies (2015-2020)
Table 13. Global Zonisamide Sales Share by Company (2015-2020)
Table 14. Global Zonisamide Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Zonisamide Revenue Share by Company (2015-2020)
Table 16. Global Zonisamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zonisamide as of 2019)
Table 17. Global Zonisamide Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Zonisamide Manufacturing Sites and Area Served
Table 19. Manufacturers Zonisamide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Zonisamide Players
Table 22. Global Zonisamide Sales (K MT) by Type (2015-2020)
Table 23. Global Zonisamide Sales Share by Type (2015-2020)
Table 24. Global Zonisamide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Zonisamide Price (K MT) by Type (2015-2020)
Table 26. Global Zonisamide Sales Share by Type (2021-2026)
Table 27. Global Zonisamide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Zonisamide Revenue Share by Type (2021-2026)
Table 29. Global Zonisamide Price (K MT) by Type (2021-2026)
Table 30. Global Zonisamide Sales (K MT) by Application (2015-2020)
Table 31. Global Zonisamide Sales Share by Application (2015-2020)
Table 32. Global Zonisamide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Zonisamide Price (K MT) by Application (2015-2020)
Table 34. Global Zonisamide Sales (K MT) by Application (2021-2026)
Table 35. Global Zonisamide Sales Share by Application (2021-2026)
Table 36. Global Zonisamide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Zonisamide Revenue Share by Application (2021-2026)
Table 38. Global Zonisamide Price (K MT) by Application (2021-2026)
Table 39. United States Zonisamide Sales (K MT) by Company (2015-2020)
Table 40. United States Zonisamide Sales Market Share by Company (2015-2020)
Table 41. United States Zonisamide Sales (K MT) by Type (2015-2020)
Table 42. United States Zonisamide Sales Market Share by Type (2015-2020)
Table 43. United States Zonisamide Sales (K MT) by Application (2015-2020)
Table 44. United States Zonisamide Sales Market Share by Application (2015-2020)
Table 45. Europe Zonisamide Sales (K MT) by Company (2015-2020)
Table 46. Europe Zonisamide Sales Market Share by Company (2015-2020)
Table 47. Europe Zonisamide Sales (K MT) by Type (2015-2020)
Table 48. Europe Zonisamide Sales Market Share by Type (2015-2020)
Table 49. Europe Zonisamide Sales (K MT) by Application (2015-2020)
Table 50. Europe Zonisamide Sales Market Share by Type (2015-2020)
Table 51. China Zonisamide Sales (K MT) by Company (2015-2020)
Table 52. China Zonisamide Sales Market Share by Company (2015-2020)
Table 53. China Zonisamide Sales (K MT) by Type (2015-2020)
Table 54. China Zonisamide Sales Market Share by Type (2015-2020)
Table 55. China Zonisamide Sales (K MT) by Application (2015-2020)
Table 56. China Zonisamide Sales Market Share by Application (2015-2020)
Table 57. Japan Zonisamide Sales (K MT) by Company (2015-2020)
Table 58. Japan Zonisamide Sales Market Share by Company (2015-2020)
Table 59. Japan Zonisamide Sales (K MT) by Type (2015-2020)
Table 60. Japan Zonisamide Sales Market Share by Type (2015-2020)
Table 61. Japan Zonisamide Sales (K MT) by Application (2015-2020)
Table 62. Japan Zonisamide Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Zonisamide Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Zonisamide Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Zonisamide Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Zonisamide Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Zonisamide Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Zonisamide Sales Market Share by Application (2015-2020)
Table 69. India Zonisamide Sales (K MT) by Company (2015-2020)
Table 70. India Zonisamide Sales Market Share by Company (2015-2020)
Table 71. India Zonisamide Sales (K MT) by Type (2015-2020)
Table 72. India Zonisamide Sales Market Share by Type (2015-2020)
Table 73. India Zonisamide Sales (K MT) by Application (2015-2020)
Table 74. India Zonisamide Sales Market Share by Application (2015-2020)
Table 75. Concordia Corporation Information
Table 76. Concordia Description and Business Overview
Table 77. Concordia Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Concordia Zonisamide Product
Table 79. Concordia Recent Development
Table 80. Eisai Corporation Information
Table 81. Eisai Description and Business Overview
Table 82. Eisai Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eisai Zonisamide Product
Table 84. Eisai Recent Development
Table 85. Zydus Pharmaceuticals Corporation Information
Table 86. Zydus Pharmaceuticals Description and Business Overview
Table 87. Zydus Pharmaceuticals Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Zydus Pharmaceuticals Zonisamide Product
Table 89. Zydus Pharmaceuticals Recent Development
Table 90. Sun Pharma Corporation Information
Table 91. Sun Pharma Description and Business Overview
Table 92. Sun Pharma Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sun Pharma Zonisamide Product
Table 94. Sun Pharma Recent Development
Table 95. Wockhardt Corporation Information
Table 96. Wockhardt Description and Business Overview
Table 97. Wockhardt Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Wockhardt Zonisamide Product
Table 99. Wockhardt Recent Development
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Mylan Zonisamide Product
Table 104. Mylan Recent Development
Table 105. APOTEX Corporation Information
Table 106. APOTEX Description and Business Overview
Table 107. APOTEX Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. APOTEX Zonisamide Product
Table 109. APOTEX Recent Development
Table 110. Teva Corporation Information
Table 111. Teva Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Teva Description and Business Overview
Table 113. Teva Zonisamide Product
Table 114. Teva Recent Development
Table 115. Glenmark Corporation Information
Table 116. Glenmark Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Glenmark Description and Business Overview
Table 118. Glenmark Zonisamide Product
Table 119. Glenmark Recent Development
Table 120. Bluepharma Corporation Information
Table 121. Bluepharma Description and Business Overview
Table 122. Bluepharma Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Bluepharma Zonisamide Product
Table 124. Bluepharma Recent Development
Table 125. Invagen Pharmaceuticals Corporation Information
Table 126. Invagen Pharmaceuticals Description and Business Overview
Table 127. Invagen Pharmaceuticals Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Invagen Pharmaceuticals Zonisamide Product
Table 129. Invagen Pharmaceuticals Recent Development
Table 130. Intas Pharmaceuticals Corporation Information
Table 131. Intas Pharmaceuticals Description and Business Overview
Table 132. Intas Pharmaceuticals Zonisamide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Intas Pharmaceuticals Zonisamide Product
Table 134. Intas Pharmaceuticals Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Zonisamide Distributors List
Table 138. Zonisamide Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Zonisamide Product Picture
Figure 2. Global Zonisamide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Zonisamide Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Pediatric Examples
Figure 8. Geriatric Examples
Figure 9. Global Zonisamide Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Zonisamide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Zonisamide Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Zonisamide Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Zonisamide Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Zonisamide Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Zonisamide Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Zonisamide Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Zonisamide Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Zonisamide Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Zonisamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Zonisamide Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Zonisamide Players Market Share by Revenue in Zonisamide 2015 & 2019
Figure 27. Zonisamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Zonisamide Revenue Share by Type (2015-2020)
Figure 29. Global Zonisamide Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Zonisamide Revenue Share by Application (2015-2020)
Figure 31. Global Zonisamide Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Zonisamide Sales Market Share by Type in 2019
Figure 33. United States Zonisamide Sales Market Share by Type in 2019
Figure 34. Europe Zonisamide Sales Market Share by Company in 2019
Figure 35. Europe Zonisamide Sales Market Share by Type in 2019
Figure 36. Europe Zonisamide Sales Market Share by Application in 2019
Figure 37. China Zonisamide Sales Market Share by Company in 2019
Figure 38. China Zonisamide Sales Market Share by Type in 2019
Figure 39. China Zonisamide Sales Market Share by Application in 2019
Figure 40. Japan Zonisamide Sales Market Share by Company in 2019
Figure 41. Japan Zonisamide Sales Market Share by Type in 2019
Figure 42. Japan Zonisamide Sales Market Share by Application in 2019
Figure 43. Southeast Asia Zonisamide Sales Market Share by Company in 2019
Figure 44. Southeast Asia Zonisamide Sales Market Share by Type in 2019
Figure 45. Southeast Asia Zonisamide Sales Market Share by Application in 2019
Figure 46. India Zonisamide Sales Market Share by Company in 2019
Figure 47. India Zonisamide Sales Market Share by Type in 2019
Figure 48. India Zonisamide Sales Market Share by Application in 2019
Figure 49. Concordia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zydus Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. APOTEX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Glenmark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bluepharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Invagen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Intas Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Zonisamide
Figure 63. Manufacturing Process Analysis of Zonisamide
Figure 64. Zonisamide Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
成人および小児用血液濃縮器の世界市場レポート2020 Market Analysis and Insights: Global Adult and Pediatric Hemoconcentrators Market The global Adult and Pediatric Hemoconcentrators market was valued at US$ 9476 million in 2019 and will reach US$ 10810 million by the end of 2026, growing at a CAGR of 1.9% during 2020-2026. Global Adult and Pediatric…- 成人・小児用血液濃縮器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adult and Pediatric Hemoconcentrators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.8% in the forecast period of 2020 to 2025 and will expected to reach USD 10470 million by 2025, from USD 9750.4 million in 2019. The…
- 小児喘息用モニターの世界市場レポート2020 Market Analysis and Insights: Global Pediatric Asthma Monitor Market The global Pediatric Asthma Monitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Pediatric Asthma Monitor Scope and Market Size The …
- 小児用皮下埋め込み型ポートの世界市場レポート2020 A recently published report by QY Research titled Global Pediatric Implantable Port Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides …
- 小児聴力検査用デバイスの世界市場レポート2020 Market Analysis and Insights: Global Devices for Pediatric Audiometry Market The global Devices for Pediatric Audiometry market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Devices for Pediatric Audiometry Sc…